The Temporal and Hierarchical Control of Transcription Factors-Induced Liver to Pancreas Transdifferentiation

Lineage-specific transcription factors (TFs) display instructive roles in directly reprogramming adult cells into alternate developmental fates, in a process known as transdifferentiation. The present study analyses the hypothesis that despite being fast, transdifferentiation does not occur in one step but is rather a consecutive and hierarchical process. Using ectopic expression of Pdx1 in human liver cells, we demonstrate that while glugacon and somatostatin expression initiates within a day, insulin gene expression becomes evident only 2–3 days later. To both increase transdifferentiation efficiency and analyze whether the process indeed display consecutive and hierarchical characteristics, adult human liver cells were treated by three pancreatic transcription factors, Pdx1, Pax4 and Mafa (3pTFs) that control distinct hierarchical stages of pancreatic development in the embryo. Ectopic expression of the 3pTFs in human liver cells, increased the transdifferentiation yield, manifested by 300% increase in the number of insulin positive cells, compared to each of the ectopic factors alone. However, only when the 3pTFs were sequentially supplemented one day apart from each other in a direct hierarchical manner, the transdifferentiated cells displayed increased mature β-cell-like characteristics. Ectopic expression of Pdx1 followed by Pax4 on the 2nd day and concluded by Mafa on the 3rd day resulted in increased yield of transdifferentiation that was associated by increased glucose regulated c-peptide secretion. By contrast, concerted or sequential administration of the ectopic 3pTFs in an indirect hierarchical mode resulted in the generation of insulin and somatostatin co-producing cells and diminished glucose regulated processed insulin secretion. In conclusion transcription factors induced liver to pancreas transdifferentiation is a progressive and hierarchical process. It is reasonable to assume that this characteristic is general to wide ranges of tissues. Therefore, our findings could facilitate the development of cell replacement therapy modalities for many degenerative diseases including diabetes.

[1]  D. Melton,et al.  Genes, signals, and lineages in pancreas development. , 2003, Annual review of cell and developmental biology.

[2]  R. Stein,et al.  Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. , 1997, Endocrinology.

[3]  S. Efrat,et al.  Development of human insulin-producing cells for cell therapy of diabetes. , 2011, Pediatric endocrinology reviews : PER.

[4]  D. Kemp,et al.  Minireview: transcriptional regulation in pancreatic development. , 2005, Endocrinology.

[5]  Ahmed Mansouri,et al.  Opposing actions of Arx and Pax4 in endocrine pancreas development. , 2003, Genes & development.

[6]  Thomas Vierbuchen,et al.  Induction of human neuronal cells by defined transcription factors , 2011, Nature.

[7]  Lung-Ji Chang,et al.  Reprogramming liver-stem WB cells into functional insulin-producing cells by persistent expression of Pdx1- and Pdx1-VP16 mediated by lentiviral vectors , 2006, Laboratory Investigation.

[8]  B. Hogan,et al.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. , 1996, Development.

[9]  V. Vedantham,et al.  Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.

[10]  M. German,et al.  Gene expression cascades in pancreatic development , 2003, Mechanisms of Development.

[11]  P. Collombat,et al.  In vivo conversion of adult α‐cells into β‐like cells: a new research avenue in the context of type 1 diabetes , 2011, Diabetes, obesity & metabolism.

[12]  I. Barshack,et al.  Pancreatic and duodenal homeobox gene 1 induces hepatic dedifferentiation by suppressing the expression of CCAAT/enhancer‐binding protein β , 2007, Hepatology.

[13]  F. Guillemot,et al.  neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Ferber,et al.  New organs from our own tissues: liver-to-pancreas transdifferentiation , 2003, Trends in Endocrinology & Metabolism.

[15]  K. Kataoka,et al.  MafA Is a Glucose-regulated and Pancreatic β-Cell-specific Transcriptional Activator for the Insulin Gene* , 2002, The Journal of Biological Chemistry.

[16]  Douglas A. Melton,et al.  In vivo reprogramming of adult pancreatic exocrine cells to β-cells , 2008, Nature.

[17]  P. Herrera,et al.  Genes controlling pancreas ontogeny. , 2008, The International journal of developmental biology.

[18]  J. Slack,et al.  Transdifferentiation and metaplasia--switching cell types. , 2001, Current opinion in genetics & development.

[19]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[20]  J. Ferrer,et al.  Transcriptional networks controlling pancreatic development and beta cell function , 2004, Diabetologia.

[21]  R. Mirmira,et al.  Transcription factors direct the development and function of pancreatic β cells , 2003, Trends in Endocrinology & Metabolism.

[22]  S. Lipton,et al.  Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. , 2011, Cell stem cell.

[23]  K. Docherty,et al.  Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic β cell , 2008, Molecular and Cellular Endocrinology.

[24]  S. Bonner-Weir,et al.  Expression of MafA in pancreatic progenitors is detrimental for pancreatic development. , 2009, Developmental biology.

[25]  S. Polak‐Charcon,et al.  Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Fujimiya,et al.  NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice , 2003, Nature Medicine.

[27]  S. Ferber,et al.  Exendin-4 Promotes Liver Cell Proliferation and Enhances the PDX-1-induced Liver to Pancreas Transdifferentiation Process* , 2009, The Journal of Biological Chemistry.

[28]  B. Gauthier,et al.  A focus on the role of Pax4 in mature pancreatic islet beta-cell expansion and survival in health and disease. , 2008, Journal of molecular endocrinology.

[29]  S. Ferber,et al.  Adult cell fate reprogramming: converting liver to pancreas. , 2010, Methods in molecular biology.

[30]  S. Bonner-Weir,et al.  Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells , 2011, Diabetologia.

[31]  M. Borowiak The new generation of beta-cells: replication, stem cell differentiation, and the role of small molecules. , 2010, The review of diabetic studies : RDS.

[32]  A. Schnerch,et al.  Direct conversion of human fibroblasts to multilineage blood progenitors , 2010, Nature.

[33]  Lu Shun,et al.  Role of Pax4 in Pdx1-VP16-mediated liver-to-endocrine pancreas transdifferentiation , 2006, Laboratory Investigation.

[34]  C. Newgard,et al.  Increase in PDX-1 levels suppresses insulin gene expression in RIN 1046-38 cells. , 1999, Endocrinology.

[35]  H. Kaneto,et al.  A Crucial Role of MafA as a Novel Therapeutic Target for Diabetes*♦ , 2005, Journal of Biological Chemistry.

[36]  P. Serup,et al.  Specifying pancreatic endocrine cell fates , 2006, Mechanisms of Development.

[37]  R. Stein,et al.  Islet-1 is Required for the Maturation, Proliferation, and Survival of the Endocrine Pancreas , 2009, Diabetes.

[38]  I. Barshack,et al.  Functional, Persistent, and Extended Liver to Pancreas Transdifferentiation* , 2003, Journal of Biological Chemistry.

[39]  L. Chan,et al.  Minireview: beta-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation. , 2010, Molecular endocrinology.

[40]  J. Jameson,et al.  Islet cell differentiation in liver by combinatorial expression of transcription factors neurogenin-3, BETA2, and RIPE3b1. , 2007, Biochemical and biophysical research communications.

[41]  H. Kaneto,et al.  MafA regulates expression of genes important to islet beta-cell function. , 2007, Molecular endocrinology.

[42]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Polak‐Charcon,et al.  Human Liver Cells Expressing Albumin and Mesenchymal Characteristics Give Rise to Insulin-Producing Cells , 2011, Journal of transplantation.

[44]  A Afek,et al.  Tissue-specific gene therapy directed to tumor angiogenesis , 2001, Gene Therapy.

[45]  J. Habener,et al.  Homeodomain Protein IDX-1 A Master Regulator of Pancreas Development and Insulin Gene Expression , 1997, Trends in Endocrinology & Metabolism.

[46]  H. Kaneto,et al.  PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance. , 2005, Diabetes.

[47]  S. Ferber,et al.  Regenerative medicine: using liver to generate pancreas for treating diabetes. , 2006, The Israel Medical Association journal : IMAJ.

[48]  Masaki Ieda,et al.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. , 2010, Cell.

[49]  S. Ferber,et al.  NKX6.1 promotes PDX-1-induced liver to pancreatic β-cells reprogramming. , 2010, Cellular reprogramming.

[50]  M. Kay,et al.  Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[51]  D. Eberhard,et al.  The pancreatic beta-cell in the islet and organ community. , 2009, Current opinion in genetics & development.

[52]  H. Kaneto,et al.  MafA Regulates Expression of Genes Important to Islet β-Cell Function , 2007 .

[53]  G. Pelled,et al.  Genetically modified cells in regenerative medicine and tissue engineering. , 2010, Advanced drug delivery reviews.

[54]  G. Webb,et al.  Abrogation of protein convertase 2 activity results in delayed islet cell differentiation and maturation, increased alpha-cell proliferation, and islet neogenesis. , 2003, Endocrinology.